Immatics NV (IMTX)
8.69
-0.24
(-2.69%)
USD |
NASDAQ |
Aug 24, 16:00
8.70
+0.01
(+0.12%)
After-Hours: 20:00
Immatics Enterprise Value : 754.82M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 754.82M |
| August 21, 2026 | 787.62M |
| August 20, 2026 | 735.68M |
| August 19, 2026 | 831.36M |
| August 18, 2026 | 809.49M |
| August 17, 2026 | 831.36M |
| August 14, 2026 | 857.34M |
| August 13, 2026 | 877.84M |
| August 12, 2026 | 894.24M |
| August 11, 2026 | 899.71M |
| August 10, 2026 | 895.61M |
| August 07, 2026 | 886.04M |
| August 06, 2026 | 854.60M |
| August 05, 2026 | 902.44M |
| August 04, 2026 | 849.13M |
| August 03, 2026 | 799.93M |
| July 31, 2026 | 750.72M |
| July 30, 2026 | 824.53M |
| July 29, 2026 | 795.82M |
| July 28, 2026 | 760.97M |
| July 27, 2026 | 746.62M |
| July 24, 2026 | 808.13M |
| July 23, 2026 | 836.83M |
| July 22, 2026 | 820.43M |
| July 21, 2026 | 853.23M |
| Date | Value |
|---|---|
| July 20, 2026 | 828.63M |
| July 17, 2026 | 877.84M |
| July 16, 2026 | 851.87M |
| July 15, 2026 | 861.44M |
| July 14, 2026 | 845.03M |
| July 13, 2026 | 828.63M |
| July 10, 2026 | 890.14M |
| July 09, 2026 | 928.41M |
| July 08, 2026 | 931.15M |
| July 07, 2026 | 969.42M |
| July 06, 2026 | 932.52M |
| July 02, 2026 | 927.05M |
| July 01, 2026 | 913.38M |
| June 30, 2026 | 951.65M |
| June 29, 2026 | 801.37M |
| June 26, 2026 | 795.90M |
| June 25, 2026 | 796.59M |
| June 24, 2026 | 864.24M |
| June 23, 2026 | 849.20M |
| June 22, 2026 | 831.44M |
| June 18, 2026 | 831.44M |
| June 17, 2026 | 795.90M |
| June 16, 2026 | 737.13M |
| June 15, 2026 | 783.60M |
| June 12, 2026 | 776.77M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| MediGene AG | -- |
| InflaRx NV | 121.83M |
| BioNTech SE | 11.81B |
| Moderna, Inc. | 51.57B |
| Intellia Therapeutics, Inc. | 1.394B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -72.66M |
| Revenue (Quarterly) | 10.63M |
| Total Expenses (Quarterly) | 83.29M |
| EPS Diluted (Quarterly) | -0.5316 |
| Profit Margin (Quarterly) | -683.4% |
| Earnings Yield | -21.28% |
| Normalized Earnings Yield | -21.29 |